Pharmacological differences among CysLT(1) receptor antagonists with respect to LTC(4) and LTD(4) in human lung parenchyma.
about
Determination of structure and transcriptional regulation of CYSLTR1 and an association study with asthma and rhinitisA review on leukotrienes and their receptors with reference to asthmaUpdate on leukotriene, lipoxin and oxoeicosanoid receptors: IUPHAR Review 7Leukotriene pathways and in vitro adenotonsillar cell proliferation in children with obstructive sleep apneaMontelukast in the treatment of asthma as a systemic disease.Montelukast in the treatment of asthma and beyond.Characterization of enzymes responsible for biotransformation of the new antileukotrienic drug quinlukast in rat liver microsomes and in primary cultures of rat hepatocytes.Montelukast, a cysteinyl leukotriene receptor-1 antagonist, dose- and time-dependently protects against focal cerebral ischemia in mice.Treatment of chronic cough in children with montelukast,a leukotriene receptor antagonist.Heterogeneous effect of leucotriene CysLT1 receptor antagonists on antigen-induced motor and inflammatory responses in guinea-pig airways.
P2860
Q28245735-94FCC7CB-B6E3-44C0-B394-1D160DDE6BBAQ28294597-909E7137-DB38-4D41-96A4-994BA0701250Q28308192-18AA880E-D8E5-4C63-9284-04B460444434Q37277243-400A1995-2D99-4521-9BBB-A27A4DAB1345Q37754612-87256FF2-C17A-4D08-BCB3-912C58B0C5B7Q37755326-B2A644FC-B487-4A7F-A530-8E6D370C218EQ44789800-DBD98372-292E-4387-BF98-296FD4DE52BEQ45081533-AF08982D-CC55-435D-80B0-2BF22448D80DQ45177542-863FD2A7-0FAA-454A-802B-6D12A4858293Q46871047-BC0E961F-BE61-44A4-B5E7-8050C170002A
P2860
Pharmacological differences among CysLT(1) receptor antagonists with respect to LTC(4) and LTD(4) in human lung parenchyma.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Pharmacological differences among CysLT
@nl
Pharmacological differences am ...... D(4) in human lung parenchyma.
@en
type
label
Pharmacological differences among CysLT
@nl
Pharmacological differences am ...... D(4) in human lung parenchyma.
@en
prefLabel
Pharmacological differences among CysLT
@nl
Pharmacological differences am ...... D(4) in human lung parenchyma.
@en
P2093
P1476
Pharmacological differences am ...... TD(4) in human lung parenchyma
@en
P2093
Saula Ravasi
Simonetta Nicosia
Tiziana Panigalli
P304
P356
10.1016/S0006-2952(02)00889-4
P407
P577
2002-04-01T00:00:00Z